FDA Issues Drug Safety Communication for Evamist (estradiol transdermal spray)
Evamist is a topical product, sprayed on the skin on the inside of the forearm between the elbow and the wrist. The FDA is currently reviewing reported adverse events and is working with the company to identify any factors that may contribute to unintended exposure. The Agency will update the public when this review is complete. FDA and the company are also evaluating ways to minimize the risk.
Want to read the full alert and receive alert emails?